BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23234451)

  • 1. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
    Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyspnea and activity limitation in COPD: mechanical factors.
    O'Donnell DE; Laveneziana P
    COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.
    Langer D; Ciavaglia CE; Neder JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2014 Dec; 8(6):731-49. PubMed ID: 25159007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
    Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
    Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
    Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
    J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease.
    Laveneziana P; Parker CM; O'Donnell DE
    Appl Physiol Nutr Metab; 2007 Dec; 32(6):1225-38. PubMed ID: 18059601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diaphragmatic mobility on exercise tolerance and dyspnea in patients with COPD.
    Paulin E; Yamaguti WP; Chammas MC; Shibao S; Stelmach R; Cukier A; Carvalho CR
    Respir Med; 2007 Oct; 101(10):2113-8. PubMed ID: 17644365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD?
    Laveneziana P; Webb KA; Wadell K; Neder JA; O'Donnell DE
    Respir Physiol Neurobiol; 2014 Aug; 199():24-33. PubMed ID: 24793133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of exercise dyspnea in healthy subjects and in patients with chronic obstructive pulmonary disease (COPD).
    Grazzini M; Stendardi L; Gigliotti F; Scano G
    Respir Med; 2005 Nov; 99(11):1403-12. PubMed ID: 16210095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in pharmacotherapy for dyspnea in COPD.
    Raghavan N; Webb K; Amornputtisathaporn N; O'Donnell DE
    Curr Opin Pharmacol; 2011 Jun; 11(3):204-10. PubMed ID: 21450522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The major limitation to exercise performance in COPD is dynamic hyperinflation.
    O'Donnell DE; Webb KA
    J Appl Physiol (1985); 2008 Aug; 105(2):753-5; discussion 755-7. PubMed ID: 18678624
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.
    Stevenson NJ; Walker PP; Costello RW; Calverley PM
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1510-6. PubMed ID: 16166620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
    Peters MM; Webb KA; O'Donnell DE
    Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.
    Calligaro GL; Raine RI; Bateman ME; Bateman ED; Cooper CB
    COPD; 2014 Feb; 11(1):105-12. PubMed ID: 24152211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. The real cause of exercise limitation in COPD.
    Wagner PD
    J Appl Physiol (1985); 2008 Aug; 105(2):758. PubMed ID: 18678625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamic lung hyperinflation and its clinical implication in COPD].
    O'donnell DE
    Rev Mal Respir; 2008 Dec; 25(10):1305-18. PubMed ID: 19107020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of dyspnea in chronic lung disease.
    Rock LK; Schwartzstein RM
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):102-8. PubMed ID: 18685350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.